Kim, Hye-Jung
Dana-Farber Cancer Institute
4 papers on CoChatORCID 0000-0001-5595-4264
Most cited papers
- Verified
PARP inhibition elicits STING-dependent antitumor immunity in brca1-deficient ovarian cancer
Ding, L., Kim, H.-J., Wang, Q., Kearns, M., Jiang, T., Ohlson, C. E., Li, B. B., Xie, S., Liu, J. F., Stover, E. H., et al. (2018) · Cell Reports
PARP inhibition in cancer therapyCancer Immunotherapy and Biomarkers
Cited by 572
- Verified
Proinflammatory T helper type 17 cells are effective B-cell helpers
Mitsdoerffer, M., Lee, Y., Jäger, A., Kim, H.-J., Korn, T., Kolls, J. K., Cantor, H., Bettelli, E., & Kuchroo, V. K. (2010) · Proceedings of the National Academy of Sciences
T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis
Cited by 534
- Verified
Stable inhibitory activity of regulatory T cells requires the transcription factor Helios
Kim, H.-J., Barnitz, R. A., Kreslavsky, T., Brown, F. D., Moffett, H., Lemieux, M. E., Kaygusuz, Y., Meissner, T., Holderried, T. A. W., Chan, S., et al. (2015) · Science
T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis
Cited by 441
- Verified
Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells
Yates, K., Bi, K., Haining, W. N., Cantor, H., & Kim, H.-J. (2018) · Proceedings of the National Academy of Sciences
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 55
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free